HomeParicalcitol

Paricalcitol

Also known as: Paricalcitol

Vitamin D2 AnalogVitamin D Analog

Route: Intravenous

Check Paricalcitol Interactions →
24 interactions on record

Paricalcitol has 24 known drug interactions based on U.S. FDA drug labeling data. 18 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Andthiazide, Calcium Antagonists, Clarithromycin. Patients taking Paricalcitol should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
24
Major
18
Moderate
5

Major (18)

  • Paricalcitol + AndthiazideThiazide diuretics induce hypercalcemia by reducing urinary calcium excretion. Monitor calcium frequently and adjust par
  • Paricalcitol + Calcium AntagonistsConcomitant administration of high doses may increase risk of hypercalcemia. Monitor calcium frequently and adjust paric
  • Paricalcitol + ClarithromycinStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + ConivaptanStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + Digitalis GlycosidesParicalcitol-induced hypercalcemia can potentiate digitalis toxicity risk. Monitor for digitalis toxicity signs and incr
  • Paricalcitol + Grapefruit JuiceStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + IndinavirStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + ItraconazoleStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + KetoconazoleStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + Lopinavir And RitonavirStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + MibefradilStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + NefazodoneStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + NelfinavirStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + PosaconazoleStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + RitonavirStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + SaquinavirStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c
  • Paricalcitol + Vitamin DConcomitant administration of high doses may increase risk of hypercalcemia. Monitor calcium frequently and adjust paric
  • Paricalcitol + VoriconazoleStrong CYP3A inhibitor increases paricalcitol exposure. Dose adjustment may be necessary; monitor intact PTH and serum c

Moderate (5)

  • Paricalcitol + BoceprevirStrong CYP3A inhibitor that increases paricalcitol exposure. Dose adjustment may be necessary; monitor iPTH and serum ca
  • Paricalcitol + Cholestyramine LightImpairs intestinal absorption of fat-soluble vitamins and may reduce paricalcitol absorption. Separate dosing by at leas
  • Paricalcitol + Multivitamin/MineralMay affect fat absorption and reduce paricalcitol absorption. Separate dosing by at least 1 hour before or 4-6 hours aft
  • Paricalcitol + TelaprevirStrong CYP3A inhibitor that increases paricalcitol exposure. Dose adjustment may be necessary; monitor iPTH and serum ca
  • Paricalcitol + TelithromycinStrong CYP3A inhibitor that increases paricalcitol exposure. Dose adjustment may be necessary; monitor iPTH and serum ca

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.